![Human Anti-Human CD20 (Obinutuzumab) Monoclonal Antibody, clone Obinutuzumab [Biosimilar]产品图](https://img1.dxycdn.com/p/s14/2026/0714/125/8239716066925696702.jpg)
Human Anti-Human CD20 (Obinutu
zumab) Monoclonal Antibody, clone Obinutuzumab [Biosimilar]- 询价
- 北京安必奇
- CABT-Z687H
- 2026年07月14日
- FA
- Human
- Human
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 抗体名：
CD20 antibody
- 抗体英文名：
Human Anti-Human CD20 (Obinutuzumab) Monoclonal Antibody, clone Obinutuzumab [Biosimilar]
- 靶点：
CD20
- 浓度：
Lot specific
- 应用范围：
FA
- 宿主：
Human
- 适应物种：
Human
- 保质期：
See COA
- 抗原来源：
Native Protein
- 级别：
RUO
- 库存：
In Stock
- 标记物：
Functional Grade
- 克隆性：
Monoclonal
- 保存条件：
Store at 2-8℃ for short term; -80℃ for long term. Avoid freeze / thaw cycle.
- 形态：
Liquid
- 亚型：
IgG1
- 免疫原：
Human CD20.
- 规格：
5 mg
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验attractive not only for studying various aspect of BCR signaling but also for the generation of human monoclonal antibody and the analysis of the human B cell repertoire. This chapter describes an efficient method to immortalize and clone human B cells
Production of a Human Antibody Library in the Phage-Display Vector pSEX81
Human monoclonal antibodies (MAbs) are more suitable than MAbs of animal origin for clinical applications because of lower hypersensitivity reactions, less formation of circulating immune complexes and lower anti-immunoglobulin responses
【翻译】Development trends for monoclonal antibody cancer therapeutics
). However, since 2000, humanized and human mAbs have been entering clinical study at approximately the same rate (4.3 versus 4.5 mAbs per year, respectively). Figure 1 | Categories of monoclonal antibody cancer therapeutics entering clinical study during 1980–1989
技术资料暂无技术资料 索取技术资料
